← Eichor
Condition: Tumor Cell Circulating Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tumor Cell Circulating

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC
Phase N/A · 1 location(s) · Fang Wu · NCT05198154A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07224750Sweden Cancerome Analysis Network - Breast Recurrence (SCAN-B-rec)
Phase N/A · 2 location(s) · Lund University Hospital · NCT03758976Establishment of a Tumor Bank for Blood Samples
Phase N/A · 6 location(s) · Medical University of Vienna · NCT01763125The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer
NA · 4 location(s) · Thomas Jefferson University · NCT05502523Circulating Immunes Cells, Cytokines and Brain Radiotherapy
NA · 1 location(s) · Centre Francois Baclesse · NCT05082961Proteomics in Small Cell Lung Cancer
Phase N/A · 1 location(s) · Aalborg University Hospital · NCT05623956Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognosticat
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT06678724Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT06885879Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT07516678Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA
NA · 2 location(s) · Institut Curie · NCT05354765Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/
Phase N/A · 1 location(s) · Shanghai Chest Hospital · NCT06358222Monitoring of Patients With Low-grade Gliomas Using Circulating miRNA
Phase N/A · 1 location(s) · University Hospital, Caen · NCT06610851ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer
Phase 2 · 1 location(s) · University of Miami · NCT06902272Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06833632Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer
Phase 3 · 1 location(s) · University of Rome Tor Vergata · NCT07067749Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell
Phase N/A · 1 location(s) · University of Jena · NCT04902937Detecting HPV DNA in Anal and Cervical Cancers
Phase N/A · 2 location(s) · University of Chicago · NCT04857528A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC
Phase 2 · 1 location(s) · Shanghai Chest Hospital · NCT07058519Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer
Phase N/A · 2 location(s) · Shengjing Hospital · NCT04065321Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
Phase N/A · 1 location(s) · Geneplus-Beijing Co. Ltd. · NCT05965557Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT07524114ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
Phase N/A · 3 location(s) · Duke University · NCT06141993A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06736613NSCLC Liquid Biopsies and Exhaled VOC
Phase N/A · 1 location(s) · St. Joseph's Healthcare Hamilton · NCT06707519Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics
Phase N/A · 1 location(s) · Baohui Han · NCT07399210Dynamic Changes in Circulating Tumour Cells Protein Expression
Phase 2 · 1 location(s) · Matteo's Friends · NCT06314997Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer
Phase 1 · 1 location(s) · University of Chicago · NCT06005324On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer
Phase N/A · 3 location(s) · Region Skane · NCT06877637Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
Phase N/A · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT03655015
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.